The growth of Viagra and its impact on the drug landscape presents a complicated question for shareholders. While the early sales data were remarkable, the intellectual property has lapsed, leading to a wave of copycat https://rorynids129708.blogprodesign.com/62805879/sildenafil-and-big-pharma-a-risky-opportunity